Evaluation of Markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains

Neurochemical Research

Volumn 36, Issue 8, 2011, Pages 1452-1463

  Mythri, Rajeswara Babu ^a   Venkateshappa, C ^a   Harish, G ^a   Mahadevan, Anita ^a   Muthane, Uday B ^a,b   Yasha, T C ^a   Srinivas Bharath, M M ^a   Shankar, S K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b Micro Lab Ltd Compound   (India)

Author keywords

Caudate nucleus; Frontal cortex; Glial fibrillary acidic protein; Glutathione; Parkinson's disease; Protein nitration; Protein oxidation; Putamen

Indexed keywords

CATALASE; GAMMA GLUTAMYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; ASTROCYTE; CAUDATE NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MALE; NITRATION; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASTROCYTES; BIOLOGICAL MARKERS; CORPUS STRIATUM; DOPAMINERGIC NEURONS; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 79961207643     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0471-9     Document Type: Article

References (76)

1. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 6067254 1:STN:280:DyaF2s7jvFSgsg%3D%3D
2. JD Adams Jr ML Chang L Klaidman 2001 Parkinson's disease-redox mechanisms Curr Med Chem 8 809 814 11375751 1:CAS:528:DC%2BD3MXjsVChur4%3D
3. MF Beal 1992 Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31 119 130 1349466 10.1002/ana.410310202 1:CAS:528:DyaK38XhsV2itrk%3D
4. Jenner P, Dexter DT, Sian J et al. (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32(Suppl): S82-S87
5. Koiliatsos VE (1998) Parkinson's disease. In: Burke RE (ed) Cell death and disease of the nervous system. Humana Press, Totowa, pp 459-475
6. LM Sayre MA Smith G Perry 2001 Chemistry and biochemistry of oxidative stress in neurodegenerative disease Curr Med Chem 8 721 738 11375746 1:CAS:528:DC%2BD3MXjsVChtbs%3D (Pubitemid 32427903)
7. S Bharath M Hsu D Kaur, et al. 2002 Glutathione, iron and Parkinson's disease Biochem Pharmacol 64 1037 1048 12213603 10.1016/S0006-2952(02)01174-7 1:CAS:528:DC%2BD38Xms1ymsbw%3D (Pubitemid 35232279)
8. DT Dexter CJ Carter FR Wells, et al. 1989 Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J Neurochem 52 381 389 2911023 10.1111/j.1471-4159.1989.tb09133.x 1:CAS:528:DyaL1MXhtFalsrc%3D (Pubitemid 19037600)
9. A Yoritaka N Hattori K Uchida, et al. 1996 Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease Proc Natl Acad Sci USA 93 2696 2701 8610103 10.1073/pnas.93.7.2696 1:CAS:528:DyaK28XitVCis7Y%3D (Pubitemid 26114311)
10. ZI Alam A Jenner SE Daniel, et al. 1997 Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra J Neurochem 69 1196 1203 9282943 10.1046/j.1471-4159.1997. 69031196.x 1:CAS:528:DyaK2sXls1Chtbs%3D (Pubitemid 27364841)
11. DT Dexter FR Wells AJ Lees, et al. 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J Neurochem 52 1830 1836 2723638 10.1111/j.1471-4159.1989.tb07264.x 1:CAS:528:DyaL1MXkslGrs7k%3D (Pubitemid 19140770)
12. E Sofic W Paulus K Jellinger, et al. 1991 Selective increase of iron in substantia nigra zona compacta of parkinsonian brains J Neurochem 56 978 982 1704426 10.1111/j.1471-4159.1991.tb02017.x 1:CAS:528:DyaK3MXhsVSqsLo%3D (Pubitemid 21922711)
13. ZI Alam SE Daniel AJ Lees, et al. 1997 A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J Neurochem 69 1326 1329 9282961 10.1046/j.1471-4159.1997.69031326.x 1:CAS:528:DyaK2sXls1Chu70%3D (Pubitemid 27364859)
14. E Floor MG Wetzel 1998 Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J Neurochem 70 268 275 9422371 10.1046/j.1471-4159.1998.70010268.x 1:CAS:528:DyaK1cXmt1Wg (Pubitemid 28020852)
15. PF Good A Hsu P Werner, et al. 1998 Protein nitration in Parkinson's disease J Neuropathol Exp Neurol 57 338 342 9600227 10.1097/00005072-199804000- 00006 1:STN:280:DyaK1c3mtVymtg%3D%3D (Pubitemid 28182632)
16. B Blanchard-Fillion D Prou M Polydoro, et al. 2006 Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells J Neurosci 26 6124 6130 16763020 10.1523/JNEUROSCI.1038-06.2006 1:CAS:528:DC%2BD28XmtFSls7g%3D
17. SR Danielson JK Andersen 2008 Oxidative and nitrative protein modifications in Parkinson's disease Free Radic Biol Med 44 1787 1794 18395015 10.1016/j.freeradbiomed.2008.03.005 1:CAS:528:DC%2BD1cXls1Sisbc%3D
18. RJ Ferrante P Hantraye E Brouillet, et al. 1999 Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase Brain Res 823 177 182 10095024 10.1016/S0006-8993(99)01166-X 1:CAS:528:DyaK1MXhvVCntL4%3D (Pubitemid 29225506)
19. E Hasegawa K Takeshige T Oishi, et al. 1990 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochem Biophys Res Commun 170 1049 1055 2167668 10.1016/0006-291X(90)90498-C 1:CAS:528:DyaK3cXls1Oisrs%3D (Pubitemid 20273373)
20. H Ischiropoulos JS Beckman 2003 Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111 163 169 12531868 1:CAS:528:DC%2BD3sXlsVGkuw%3D%3D (Pubitemid 36105911)
21. S Pennathur V Jackson-Lewis S Przedborski, et al. 1999 Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o, o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease J Biol Chem 274 34621 34628 10574926 10.1074/jbc.274.49.34621 1:CAS:528:DyaK1MXnvFyrsrs%3D (Pubitemid 129509499)
22. PM Keeney J Xie RA Capaldi, et al. 2006 Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled J Neurosci 26 5256 5264 16687518 10.1523/JNEUROSCI. 0984-06.2006 1:CAS:528:DC%2BD28Xlt1Cisrk%3D (Pubitemid 44315308)
23. AH Schapira JM Cooper D Dexter, et al. 1990 Mitochondrial complex I deficiency in Parkinson's disease J Neurochem 54 823 827 2154550 10.1111/j.1471-4159.1990.tb02325.x 1:CAS:528:DyaK3cXhsFKiur4%3D
24. B Jagatha RB Mythri S Vali, et al. 2008 Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies Free Radic Biol Med 44 907 917 18166164 10.1016/j.freeradbiomed.2007.11.011 1:CAS:528: DC%2BD1cXhslGrt78%3D
25. J Rogers D Mastroeni B Leonard, et al. 2007 Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82 235 246 17678964 10.1016/S0074-7742(07)82012-5 1:CAS:528:DC%2BD2sXhtVWqs77L
26. CJ Werner R Heyny-von Haussen G Mall, et al. 2008 Proteome analysis of human substantia nigra in Parkinson's disease Proteome Sci 6 8 18275612 10.1186/1477-5956-6-8 (Pubitemid 351385673)
27. H Braak K Del Tredici U Rub, et al. 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 12498954 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
28. PA Alladi A Mahadevan SK Shankar, et al. 2010 Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians J Chem Neuroanat 40 43 52 20347960 10.1016/j.jchemneu.2010. 03.007 1:CAS:528:DC%2BC3cXlsFWisLs%3D
29. PA Alladi A Mahadevan K Vijayalakshmi, et al. 2010 Ageing enhances alpha-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians Neurochem Int 57 530 539 20615443 10.1016/j.neuint.2010.06.018 1:CAS:528:DC%2BC3cXhtFalsLvI
30. PA Alladi A Mahadevan TC Yasha, et al. 2009 Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease Neuroscience 159 236 245 19135503 10.1016/j.neuroscience.2008.11.051 1:CAS:528:DC%2BD1MXit1Orsb8%3D
31. S Karunakaran U Saeed M Mishra, et al. 2008 Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice J Neurosci 28 12500 12509 19020042 10.1523/JNEUROSCI.4511-08.2008 1:CAS:528:DC%2BD1cXhsVGmtLbO
32. S Karunakaran U Saeed S Ramakrishnan, et al. 2007 Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain Brain Res 1185 8 17 17961515 10.1016/j.brainres.2007.09.019 1:CAS:528:DC%2BD2sXhtlykurvL (Pubitemid 350176571)
33. V Agarwal RP Kommaddi K Valli, et al. 2008 Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite PLoS One 3 e2337 18545703 10.1371/journal.pone.0002337
34. SJ Chinta RP Kommaddi CM Turman, et al. 2005 Constitutive expression and localization of cytochrome P-450 1A1 in rat and human brain: presence of a splice variant form in human brain J Neurochem 93 724 736 15836631 10.1111/j.1471-4159.2005.03061.x 1:CAS:528:DC%2BD2MXktFKgurc%3D (Pubitemid 40617632)
35. R Chandana RB Mythri A Mahadevan, et al. 2009 Biochemical analysis of protein stability in human brain collected at different post-mortem intervals Indian J Med Res 129 189 199 19293447 1:CAS:528:DC%2BD1MXksVGqsbk%3D
36. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 36810 10.1016/0003-2697(79)90738-3 1:CAS:528:DyaE1MXksFaisbk%3D (Pubitemid 9194347)
37. RB Mythri B Jagatha N Pradhan, et al. 2007 Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9 399 408 17184173 10.1089/ars.2006.1479 1:CAS:528:DC%2BD2sXhtlKlsb0%3D (Pubitemid 46145986)
38. IA Trounce YL Kim AS Jun, et al. 1996 Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines Methods Enzymol 264 484 509 8965721 10.1016/S0076-6879(96)64044-0 1:CAS:528:DyaK28XksVartbo%3D (Pubitemid 26089333)
39. H Aebi 1984 Catalase in vitro Methods Enzymol 105 121 126 6727660 10.1016/S0076-6879(84)05016-3 1:CAS:528:DyaL2cXltVKis7s%3D
40. TV Bagnyukova KB Storey VI Lushchak 2003 Induction of oxidative stress in Rana ridibunda during recovery from winter hibernation J Therm Biol 28 21 28 10.1016/S0306-4565(02)00031-1 1:CAS:528:DC%2BD38Xps12ksr4%3D (Pubitemid 36164273)
41. C Guthenberg P Alin B Mannervik 1985 Glutathione transferase from rat testis Methods Enzymol 113 507 510 4088072 10.1016/S0076-6879(85)13067-3 1:CAS:528:DyaL28XkslCqtA%3D%3D (Pubitemid 16195824)
42. I Carlberg B Mannervik 1985 Glutathione reductase Methods Enzymol 113 484 490 3003504 10.1016/S0076-6879(85)13062-4 1:CAS:528:DyaL28XkslCqsQ%3D%3D (Pubitemid 16195819)
43. L Flohe WA Gunzler 1984 Assays of glutathione peroxidase Methods Enzymol 105 114 121 6727659 10.1016/S0076-6879(84)05015-1 1:CAS:528:DyaL2cXltVKisbs%3D (Pubitemid 14165378)
44. F Tietze 1969 Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal Biochem 27 502 522 4388022 10.1016/0003-2697(69)90064-5 1:CAS:528:DyaF1MXktVSlt7k%3D
45. GF Seelig A Meister 1985 Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney Methods Enzymol 113 379 390 2868388 10.1016/S0076-6879(85)13050-8 1:CAS:528:DyaL28XkslCrtA%3D%3D (Pubitemid 16195807)
46. J Sian DT Dexter AJ Lees, et al. 1994 Glutathione-related enzymes in brain in Parkinson's disease Ann Neurol 36 356 361 8080243 10.1002/ana.410360306 1:STN:280:DyaK2czmtFCltw%3D%3D (Pubitemid 24280056)
47. DS Albers MF Beal 2000 Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease J Neural Transm Suppl 59 133 154 10961426 1:CAS:528:DC%2BD3MXltFGisQ%3D%3D (Pubitemid 30479414)
48. R Banerjee AA Starkov MF Beal, et al. 2009 Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis Biochim Biophys Acta 1792 651 663 19059336 1:CAS:528:DC%2BD1MXnsFygs74%3D
49. MT Lin MF Beal 2006 Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 787 795 17051205 10.1038/nature05292 1:CAS:528:DC%2BD28XhtVyktbbO (Pubitemid 44622683)
50. AH Schapira JM Cooper D Dexter, et al. 1989 Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1269 2566813 10.1016/S0140-6736(89) 92366-0 1:STN:280:DyaL1M3mtVOktQ%3D%3D (Pubitemid 19140359)
51. AH Schapira VM Mann JM Cooper, et al. 1990 Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease J Neurochem 55 2142 2145 2121905 10.1111/j.1471-4159.1990.tb05809.x 1:CAS:528:DyaK3MXpvFeltw%3D%3D (Pubitemid 120021853)
52. P Jenner 1993 Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease Acta Neurol Scand Suppl 146 6 13 8333254 1:STN:280:DyaK3szisFelsg%3D%3D (Pubitemid 23251601)
53. P Damier EC Hirsch P Zhang, et al. 1993 Glutathione peroxidase, glial cells and Parkinson's disease Neuroscience 52 1 6 8433802 10.1016/0306-4522(93) 90175-F 1:STN:280:DyaK3s7msFWktg%3D%3D (Pubitemid 23026600)
54. VM Mann JM Cooper SE Daniel, et al. 1994 Complex I, iron, and ferritin in Parkinson's disease substantia nigra Ann Neurol 36 876 881 7998774 10.1002/ana.410360612 1:CAS:528:DyaK2MXjsVehsro%3D (Pubitemid 24370927)
55. RK Pearce A Owen S Daniel, et al. 1997 Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease J Neural Transm 104 661 677 9444566 10.1007/BF01291884 1:STN:280:DyaK1c7gs12ksw%3D%3D (Pubitemid 27474680)
56. TL Perry DV Godin S Hansen 1982 Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33 305 310 7162692 10.1016/0304-3940(82)90390-1 1:STN:280:DyaL3s7kt1aktA%3D%3D (Pubitemid 13119539)
57. TL Perry VW Yong 1986 Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients Neurosci Lett 67 269 274 3737015 10.1016/0304-3940(86)90320-4 1:STN:280:DyaL283osFKluw%3D%3D (Pubitemid 16038336)
58. SJ Chinta JK Andersen 2006 Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease Free Radic Biol Med 41 1442 1448 17023271 10.1016/j.freeradbiomed.2006.08.002 1:CAS:528:DC%2BD28XhtVCrtLbE (Pubitemid 44466728)
59. M Hsu B Srinivas J Kumar, et al. 2005 Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease J Neurochem 92 1091 1103 15715660 10.1111/j.1471-4159.2004.02929.x 1:CAS:528:DC%2BD2MXitleiu78%3D (Pubitemid 40344300)
60. E Clementi GC Brown M Feelisch, et al. 1998 Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione Proc Natl Acad Sci USA 95 7631 7636 9636201 10.1073/pnas.95.13.7631 1:CAS:528:DyaK1cXktFCgsr4%3D (Pubitemid 28293304)
61. S Bharath JK Andersen 2005 Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease Antioxid Redox Signal 7 900 910 15998245 10.1089/ars.2005.7.900 1:CAS:528: DC%2BD2MXlsl2is7s%3D (Pubitemid 40967141)
62. JT Greenamyre TB Sherer R Betarbet, et al. 2001 Complex I and Parkinson's disease IUBMB Life 52 135 141 11798025 10.1080/15216540152845939 1:CAS:528:DC%2BD38Xlt1Wlsg%3D%3D (Pubitemid 33731566)
63. J Sian DT Dexter AJ Lees, et al. 1994 Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348 355 8080242 10.1002/ana.410360305 1:STN:280: DyaK2czmtFCltg%3D%3D (Pubitemid 24280055)
64. P Riederer E Sofic WD Rausch, et al. 1989 Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J Neurochem 52 515 520 2911028 10.1111/j.1471-4159.1989.tb09150.x 1:CAS:528:DyaL1MXhtFals78%3D (Pubitemid 19037617)
65. JD Adams Jr LK Klaidman IN Odunze, et al. 1991 Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E Mol Chem Neuropathol 14 213 226 1958264 10.1007/BF03159937 1:CAS:528:DyaK38XkvVOru78%3D
66. SJ Chinta JM Kumar H Zhang, et al. 2006 Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease Free Radic Biol Med 40 1557 1563 16632116 10.1016/j.freeradbiomed.2005.12.023 1:CAS:528:DC%2BD28Xjsl2mur0%3D
67. J Frade S Pope M Schmidt, et al. 2008 Glutamate induces release of glutathione from cultured rat astrocytes-a possible neuroprotective mechanism? J Neurochem 105 1144 1152 18182055 10.1111/j.1471-4159.2008.05216.x 1:CAS:528:DC%2BD1cXmsVOls74%3D (Pubitemid 351590782)
68. ME Gegg B Beltran S Salas-Pino, et al. 2003 Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J Neurochem 86 228 237 12807442 10.1046/j.1471-4159.2003.01821.x 1:CAS:528:DC%2BD3sXltFelu7s%3D (Pubitemid 36753863)
69. J Sagara N Makino S Bannai 1996 Glutathione efflux from cultured astrocytes J Neurochem 66 1876 1881 8780013 10.1046/j.1471-4159.1996.66051876.x 1:CAS:528:DyaK28XisVSku74%3D (Pubitemid 26118775)
70. AY Shih DA Johnson G Wong, et al. 2003 Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress J Neurosci 23 3394 3406 12716947 1:CAS:528:DC%2BD3sXjsFSkt7o%3D (Pubitemid 36531981)
71. CP Ramsey CA Glass MB Montgomery, et al. 2007 Expression of Nrf2 in neurodegenerative diseases J Neuropathol Exp Neurol 66 75 85 17204939 10.1097/nen.0b013e31802d6da9 1:CAS:528:DC%2BD2sXhsV2qtb4%3D (Pubitemid 46066791)
72. PL McGeer S Itagaki BE Boyes, et al. 1988 Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285 1291 3399080 1:STN:280:DyaL1c3ovVKkuw%3D%3D
73. B Mirza H Hadberg P Thomsen, et al. 2000 The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease Neuroscience 95 425 432 10658622 10.1016/S0306-4522(99)00455-8 1:CAS:528:DyaK1MXnslGmu7o%3D
74. E Bertrand W Lechowicz GM Szpak, et al. 1997 Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease Folia Neuropathol 35 80 86 9377080 1:STN:280:DyaK1c%2FitVKktA%3D%3D (Pubitemid 127535387)
75. HL Martin P Teismann 2009 Glutathione-a review on its role and significance in Parkinson's disease FASEB J 23 3263 3272 19542204 10.1096/fj.08-125443 1:CAS:528:DC%2BD1MXht1GjtLnO
76. LF Lin DH Doherty JD Lile, et al. 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130 1132 8493557 10.1126/science.8493557 1:CAS:528:DyaK2cXks1Gguw%3D%3D (Pubitemid 23186789)